Skinbiotherapeutics Share Discussion Threads

[aspex] 14/6/2017 22:45

Hi John,
Take a type O with you on your next holiday. Good bait!
Just joking.
Or maybe it is just Southern Hemisphere mozzies that prefer O.
Also Polynesian people are largely type A and they get bitten anyway.
Our scourge in wetter parts of NZ is sandflies (you would call them midges)
I am told by those who know that they have been heard by a victim to say "Shall we eat him here or take him away?"

[2350220] 14/6/2017 10:48

Ha ha, don't think it's as simple as that I'm afraid aspex.
Both my wife & I are also A, she's Neg and I'm Poz (opposite to both of our nature!).
Last time we were in Italy we were both bitten to pieces.
In fact I think I overheard one mozzy telling his mate "I'm going out for a full English breakfast"

John

[aspex] 14/6/2017 09:47

If you have blood type A (like me) mosquitos are not very attracted. Good luck.

[2350220] 14/6/2017 09:37

Morning ODR,
Take your point, but one avenue I was thinking about was the 3rd World malaria issue rather than the domestic holiday market (though I know that was in my example to Dr. Cath).
All the best,
John
PS blimey, waking up to this awful news about the fire in Kensington, puts all this share dealing into perspective.

[onedayrodders] 13/6/2017 17:00

Nice of her to reply.

I'd say there already is a fairly inexpensive solution in insect and mosquito repellent creams.

I dare say any microbiome answer would be that much more expensive for doing the same thing.

What we need and what they are targeting is niche multi billion pound markets where consumers would be prepared to pay a premium for creams that make you look younger or for conditions where the competition solutions are flawed or do not work for all.

If I didn't want to get bit I'd just buy a £3 or £4 cream from Anthisan or Boots own make.

[2350220] 12/6/2017 19:12

Hi All,
An idea popped into my brain and so I wrote to Dr. Cath.
I'm very impressed that she took the time to come back to me, AND not make me feel stupid for the suggestion.
I haven't got the exact wording of my text, as I sent the suggestion via Skin Bio's website Contact page, but here's the gist:

Me:
Dear Dr. Cath,
Sorry in advance if this is going to be a stupid suggestion.
When I've been on holiday, I've noticed that some people get bitten by mosquitoes terribly, and others escape without a care.
Could there be any tie up with the people's skin microbiome?
IF so, would there be an mileage in investigating this, as the implications could be huge.

Dr. Cath's reply:
Hi John,
Thank you very much for your suggestions of looking at the microbiome and mosquito bites.
It’s not a stupid suggestion at all. IN fact it is known that mosquito’s are attracted by smell. We also know that different individuals have their own unique smell. At least some of this is almost certainly to do with the microbiome as individuals have a unique microbiomes, much like we have individual fingerprints.
I think the idea is great but at least for now SkinBioTherapeutics will be focussing on its current applications. I think your idea would make a great academic project for someone.
Best wishes,
Cath O’Neill
Chief Executive

[onedayrodders] 11/6/2017 12:27

yes now finish your homework and get the bed

;o)

[ibug] 09/6/2017 13:06

The latest edition of Microbiome News is out today --- very interesting reading about this space.

[onedayrodders] 06/6/2017 19:04

Ageed elrico ... but a little more credability to the microbiome science and a surging OPTI share price should have some impact here.

IMHO

[elrico] 06/6/2017 18:35

I noticed the SBTX investor presentation is the same day as OPTI AGM. I dare say nothing in it, unless you like a good conspiracy.

[elrico] 06/6/2017 18:34

ODR - The science has yet to be shored up via human trials. The theory works and we need to keep in mind the science is a little different than Slimbiome & LD-LPL side.

[ibug] 06/6/2017 18:14

We are waiting for the product safety approval then the clinical trials can start. The company just appointed a scientist/tech to do the trials so I envisage the timeline for the safety approval to be arriving very soon so as to dovetail with the new employee's job.

If that assumption is right then some news may well be in the offering to kick off the development schedule post IPO...and that will help make the share price sparkle.

[onedayrodders] 06/6/2017 16:55

Investor shows and seminars etc as we have seen with OPTI for a year or so, do not impact the share price to any degree or sustainability.

Apart from direct RNS news the near term catalyst for upward movement here would be if OPTI announce multiple deals over the next few weeks and months, SOH has strongly hinted at the same and some very lucrative (£5m deals possible)

That will provide a boost here as the science will be finally proven through the serious commercialization.

A few more weeks of nothing here and it's sub 10p again. That's AIM.

[aim_trader] 06/6/2017 14:27

SkinBio Therapeutics will be presenting to investors at the upcoming Proactive One2One Forum taking place on the evening of 15th June. For details and registration, please click here:

[onedayrodders] 06/6/2017 12:33

There is no way these disruptive technology stocks can just sit at a level inbetween newsflow when no revenue is in place to sustain.

Too many lottery type investors looking for the next overnight winning ticket.
10 mins is seen as long term by the majority AIM retail plonkers.

[judijudi] 06/6/2017 09:29

Top call that was Trotts :(

[ibug] 02/6/2017 09:56

SBTX research into skin bacteria is going to have some spin offs imo:

About 85% of people get acne at some point in their lives, and scientists have long blamed it on the bacterium Propionibacterium acnes. But so-called P. acnes never entirely explained acne, because research has shown that it's abundant in hair follicles of people with clear skin, too—not just those with pimples.

Now, new research puts forth a different potential acne culprit: an imbalance of bacteria living on the skin. The findings, presented recently at the Microbiology Society’s Annual conference and published in the journal Scientific Reports, suggest that balancing bacteria—not wiping it out, as antibiotic treatments do—may be one future way to battle breakouts.

[trotterstrading] 31/5/2017 10:59

Sellers dried up, nice base formed ready for the move higher :0)

[parob] 30/5/2017 12:28

Doesn't seem to be going any lower. Perhaps this is the higher low going in...

[parob] 27/5/2017 11:09

SkinBioTherapeutics Plc (LON:SBTX) CEO Dr Catherine O’Neill talks to DirectorsTalk about the extension of a contract with the University of Manchester. Catherine explains the purpose and audience of SkinBiotix, how the company will benefit from the extension of the research contract, the importance of being labelled ‘dermatologically tested’ and what investors should be looking out for in terms of news flow.

[parob] 25/5/2017 15:06

You're welcome John. If this drops to 12p to buy I'm taking a few more.

[humphries1] 25/5/2017 12:47

its safe, no bomb

[2350220] 25/5/2017 12:17

Haven't seen anything about that on the news,
John